Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-16-088448

President and CEO acquired 1,979 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

McCarthy Sean A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-11-30 Grant or award : show line 1 in the form +1,979 $9.10 $17,999 1,979 D
Loading xslF345X03/doc1.xml…